纤维素凝块在癌症中的特性:对癌症相关血栓的影响
Michał Ząbczyk1,2, Anetta Undas1,2
1Thromboembolic Disorders Department, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Seminars in thrombosis and hemostasis
|June 23, 2023
概括
癌症患者经常出现前血栓性纤维素凝块,增加静脉血栓栓塞 (VTE) 和复发的风险. 了解这些凝块特征是管理癌症相关血栓形成 (CAT) 的关键.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 癌症患者面临着静脉血栓栓塞 (VTE) 和其复发的高风险.
- 在癌症患者中观察到一种原血栓性纤维素凝块表型,其特征是更密集,更硬的凝块抵抗溶解.
- 这种表型与炎症,氧化应激,凝血激活和中性粒细胞外细胞陷有关,有助于癌症相关血栓形成 (CAT).
研究的目的:
- 审查目前对患有CAT的癌症患者纤维素凝块结构和功能的理解.
- 探索纤维素相关机制在癌症相关血栓形成和进展中的作用.
- 讨论纤维素凝块表型如何预测癌症检测并影响治疗结果.
主要方法:
- 这项研究是对现有文献的叙述性审查.
- 它综合了有关纤维素凝块特征的当前知识,在癌症相关血栓形成的背景下.
- 该审查审查了多发性骨髓瘤和肺癌和胃肠道癌症等固体癌症研究的证据.
主要成果:
- 血栓状纤维素凝块的特征在癌症患者中普遍存在,特别是那些患有多发性骨髓瘤和活跃固体癌症的人.
- 这些特征与VTE风险增加有关,并且在预测VTE患者癌症检测方面具有潜力.
- 患者的年龄和吸烟等因素,以及癌症治疗和抗凝药,可以影响纤维素凝块的特征.
结论:
- 纤维素凝块表型在与癌症相关的血栓形成中起着重要作用.
- 改变的纤维素凝块结构有助于癌症的前血栓状态.
- 需要进一步的研究来确定纤维素凝块表型是否可以预测CAT患者中复发的VTE事件.
相关概念视频
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Venous Thrombosis I: Introduction
14
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Coagulation
7.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K


